The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

11 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design, synthesis, and biological evaluation of 5-(1H-indol-5-yl)isoxazole-3-carboxylic acids as novel xanthine oxidase inhibitors.EBI
Wuhan Institute of Technology
Hybrids of delavirdine and piperdin-4-yl-aminopyrimidines (DPAPYs) as potent HIV-1 NNRTIs: Design, synthesis and biological activities.EBI
Wuhan Institute of Technology
Advances in rationally designed dual inhibitors of HIV-1 reverse transcriptase and integrase.EBI
Wuhan Institute of Technology
Pharmaceutical significance of azepane based motifs for drug discovery: A critical review.EBI
Wuhan Institute of Technology
Triazole derivatives as inhibitors of Alzheimer's disease: Current developments and structure-activity relationships.EBI
Wuhan Institute of Technology
Design and synthesis of hybrids of diarylpyrimidines and diketo acids as HIV-1 inhibitors.EBI
Wuhan Institute of Technology
A novel family of diarylpyrimidines (DAPYs) featuring a diatomic linker: Design, synthesis and anti-HIV activities.EBI
Wuhan Institute of Technology
Structure-activity relationship (SAR) studies of synthetic glycogen synthase kinase-3β inhibitors: A critical review.EBI
Wuhan Institute of Technology
Homology modeling and atomic level binding study of GABA(A) receptor with novel enaminone amides.EBI
Wuhan Institute of Technology
Structural modifications of diarylpyrimidines (DAPYs) as HIV-1 NNRTIs: Synthesis, anti-HIV activities and SAR.EBI
Wuhan Institute of Technology
Advances in diarylpyrimidines and related analogues as HIV-1 nonnucleoside reverse transcriptase inhibitors.EBI
Wuhan Institute of Technology